Cargando…
First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis
AIM: The objective of this network meta-analysis was to determine the most useful first-line therapeutic strategy for patients with advanced (IIIB/IV or relapsed) non–small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Leu858Arg or EGFR 19del mutations. METHODS: PubMed, the W...
Autores principales: | Chen, Chongxiang, Zhang, Chunning, Lin, Huaming, Liu, Qianyin, Wu, Limian, Zhou, Chengzhi, Zhang, Jiexia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580106/ https://www.ncbi.nlm.nih.gov/pubmed/36274751 http://dx.doi.org/10.1177/20406223221125706 |
Ejemplares similares
-
Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
por: Ridouane, Yassine, et al.
Publicado: (2017) -
The mutation of Trp64Arg in β3-adrenoreceptor-encoding gene is significantly associated with increased hypertension risk and elevated blood pressure: a meta-analysis
por: Yang, Hualing, et al.
Publicado: (2017) -
Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis
por: Zhu, Yixiang, et al.
Publicado: (2023) -
XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis
por: Wang, Zhiyu, et al.
Publicado: (2021) -
Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis
por: Wenfan, Fu, et al.
Publicado: (2023)